Hutchmed (China) Ltd (HCM)

TheFly reported on May 28 that Morgan Stanley upgraded HCM to Equal Weight from Underweight and set a new price target of $13.60, slightly below the prior $13.75 level.

Haig Bathgate, CEO of Callanish Capital, stated on CNBC on May 7 that he is confident about global stocks despite worries over the Iran war.

We came across a bullish thesis on Paycom Software, Inc. on The Wealth Dynasty Report’s Substack. In this article, we will summarize the bulls’ thesis on PAYC.

The pharmaceutical industry is one of the most interesting sectors to invest in.

In this article, we will take a look at the 5 best emerging markets stocks to buy according to analysts.

In this piece, we will take a look at the 12 most promising cancer stocks according to analysts.

In this article, we discuss Ray Dalio on potential US China war and rise of China.

The Insider Monkey team has completed processing the quarterly 13F filings for the June quarter submitted by the hedge funds and other money managers included in our extensive database.

In this article we are going to use hedge fund sentiment as a tool and determine whether Hutchison China MediTech Limited (NASDAQ:HCM) is a good investment right now.